Cn /En

News Center

——

Company news

Industry news

InnoModels: Introduction of iHuPBMC-NK Platform

Author:

InnoModels

Release time:

2024-02-29

In today's rapid development of biotechnology, immunotherapy has become an important means of cancer treatment. In this field, the iHuPBMC-NK platform of InnoModels Biotechnology has attracted extensive attention from the industry due to its unique advantages and features. In this paper, we will introduce the features of iHuPBMC-NK platform in detail and look forward to its application prospect in the future immunotherapy field.
I. Unique advantages of iHuPBMC-NK platform
1. Efficient NK cell proliferation: iHuPBMC-NK platform utilizes a unique culture technology that significantly improves the proliferation capacity of NK cells. Compared to traditional methods, the iHuPBMC-NK platform is able to obtain sufficient numbers of NK cells faster, shortening the treatment cycle and improving the timeliness of treatment.
2. Gene editing capability: With the help of CRISPR-Cas9 and other gene editing technologies, the iHuPBMC-NK platform is able to precisely genetically modify NK cells to give them stronger anti-tumor activity. This innovative technology will bring unprecedented breakthroughs in tumor immunotherapy.
3. Personalization: The iHuPBMC-NK platform can personalize the NK cell culture according to the patient's specific situation. This feature makes the treatment more targeted and can significantly improve the therapeutic effect and reduce side effects.
4. Safety guarantee: During the development of the iHuPBMC-NK platform, InnoModels Biotechnology strictly follows international safety standards to ensure the sterility of the entire culture and expansion process. Meanwhile, strict quality control of the culture medium is carried out to ensure the safety and effectiveness of NK cells.

Second, the application prospect of iHuPBMC-NK platform in the field of immunotherapy
1. Individualized immunotherapy: With the continuous development of precision medicine, individualized immunotherapy has become an important direction of cancer treatment. iHuPBMC-NK platform is expected to play a key role in this field by virtue of its personalized features, providing patients with more accurate and effective treatment plans.
2. Tumor immunotherapy: With the help of gene editing technology, the iHuPBMC-NK platform can enhance the anti-tumor activity of NK cells, further improving the efficacy of tumor immunotherapy. This will bring greater hope of survival for tumor patients.
3. Combination therapy strategy: In the future, the iHuPBMC-NK platform is expected to be combined with other immunotherapies or traditional therapies to form a combination therapy strategy. This multi-pronged treatment approach will be more effective against cancer and increase the cure rate.
4. Clinical trials and drug development: The iHuPBMC-NK platform can also be used to conduct clinical trials and drug development. Through this platform, researchers can evaluate the effectiveness and safety of new drugs and accelerate the drug development process.
5. Disease modeling research: In addition to direct application in patient treatment, the iHuPBMC-NK platform can also be used as a research tool to construct disease models and deeply investigate the molecular mechanisms and functions of immune cells. This will help scientists better understand the operation of the immune system and lay the foundation for future immunotherapy research.
To summarize, the iHuPBMC-NK platform of InnoModels Biotechnology has brought breakthroughs in the field of immunotherapy with its unique advantages and features. With the deepening of the research and the continuous improvement of the technology, we have reason to believe that the iHuPBMC-NK platform will play an increasingly important role in the field of immunotherapy in the future, and bring the hope of life to more patients.

InnoModels: Introducing the Advantages of the iHuPBMC-MHC/KO Platform

InnoModels: Introduction to the Features of iHuPBMC-B

InnoModels: Introducing the Advantages of the iHuPBMC-MHC/KO Platform

InnoModels: Introduction to the Features of iHuPBMC-B

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License